SkylineDx announces commercial launch Merlin™ Assay as CE-IVD kit in Europe
/PRNewswire/ -- Today, SkylineDx, a leading molecular diagnostics company, announces the commercial launch of Merlin Assay as CE-IVD distributable test kit in...
Stay updated with breaking news from Merlin Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Today, SkylineDx, a leading molecular diagnostics company, announces the commercial launch of Merlin Assay as CE-IVD distributable test kit in...
ROTTERDAM, Netherlands and SAN DIEGO, Sept. 1, 2022 /PRNewswire/ -- Today, SkylineDx, a leading molecular diagnostics company, announces the commercial launch of Merlin Assay as CE-IVD distributable
ROTTERDAM, Netherlands and SAN DIEGO, May 25, 2022 /PRNewswire/ -- Today, SkylineDx, a leading molecular diagnostics company, announces Medicare coverage for Merlin Test. The local coverage
/PRNewswire/ -- Today, SkylineDx, a leading molecular diagnostics company, announces Medicare coverage for Merlin Test. The local coverage determination was...
/PRNewswire/ -- Today, SkylineDx presents new data showing that their Merlin Test was able to prospectively reduce >37% of surgeries in a non-interventional...